Related Experiment Video
Updated: Aug 6, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Cardiovascular Disease in Males With Breast Cancer: A Population-Based Cohort Study
Anjali Chauhan1, Vasily Giannakeas2, Deva Thiruchelvam3
1Division of Cardiology, Department of Medicine, Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Male breast cancer (BC) patients have higher baseline cardiovascular disease (CVD) risk. However, adjusted analyses show no increased future CVD hazard, emphasizing cancer treatment prioritization and CVD risk management.
Area of Science:
- Oncology
- Cardiology
- Epidemiology
Background:
- Limited data exist on cardiovascular disease (CVD) risk in male breast cancer (BC).
- Understanding CVD risk in male BC is crucial for comprehensive patient care.
Purpose of the Study:
- To compare CVD risk in males with BC against females with BC and cancer-free males.
- To identify potential disparities in cardiovascular health outcomes.
Main Methods:
- A population-based cohort study utilized linked administrative databases in Ontario, Canada (1998-2021).
- Male BC patients were age-matched to female BC patients and cancer-free male controls.
- Primary outcome: CVD hospitalization/emergency department visits; Secondary outcome: cause-specific mortality. Cause-specific hazards regression was employed.
Main Results:
- Males with BC exhibited higher prevalent pre-existing CVD and risk factors compared to both comparator groups.
- Adjusted analyses revealed no significant difference in CVD hospitalization/emergency department visits for male BC versus female BC (HR: 1.03) or cancer-free males (HR: 1.00).
- Male BC was not associated with increased CVD mortality but showed higher cancer mortality.
Conclusions:
- Despite greater baseline cardiovascular risk, males with BC do not face an elevated future CVD hazard post-adjustment.
- This underscores the importance of prioritizing cancer treatment for male BC patients.
- Integrated CVD risk management strategies are essential for this population.
Related Concept Videos
Cancer Survival Analysis
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cancer Prevention
Some...
Cancer Prevention
Some...
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures